Kiichiro Toyoizumi

3PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInfectious diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 31, 2026
Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study.

|Sep 02, 2022
Bias correction based on weighted likelihood for conditional estimation of subgroup effects in randomized clinical trials.

Kiichiro Toyoizumi, Shigeyuki Matsui

|Dec 11, 2019
Designing A Pathogen-Focused Study To Address The High Unmet Medical Need Represented By Carbapenem-Resistant Gram-Negative Pathogens - The International, Multicenter, Randomized, Open-Label, Phase 3 CREDIBLE-CR Study.

Matteo Bassetti, Mari Ariyasu, Bruce Binkowitz

Pageof 1

Frequent Collaborators

1 joint publications

Mari Ariyasu

1 joint publications

Shigeyuki Matsui

1 joint publications

Barbara Burtness

1 joint publications

Ari J Rosenberg